CEO SUMMARY: Probably the most challenging infections for hospitals to control and reduce are methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff). The laboratory at one New York hospital introduced algorithms to screen for the presence of each infection. In the past five years, the hospital not only cut costs by almost $3 million […]
Leveraging Testing Technology To Identify MRSA, C. Difficile
Long Island hospital cuts costs while reducing hospital acquired infections
- By Joseph Burns
- > From the Volume XX No. 3 - March 4, 2013 Issue
- Tags: ASCP, clinical lab, Clinical Laboratory, clinical laboratory scientist, clinical laboratory scientists, clinical trials, Diagnostic technology, director of laboratory, hie, hospital laboratory, lab administrator, lab test, lab testing, laboratory scientists, laboratory service, laboratory services, laboratory test, laboratory testing, Medicare, molecular testing, new diagnostic technologies, new diagnostic technology, pathologists, pcr, pcr test, pcr testing, polymerase chain reaction, the laboratory
